MAZE THERAPEUTICS INC (MAZE) Stock Income Statement
NASDAQ:MAZE • US5787841007
Current stock price
27.005 USD
+0.43 (+1.6%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 167.50M | 0.00 | 0.00 | |||
| Operating Expenses | 142.90M | 109.91M | 98.55M | 111.03M | |||
| Research and Development | 108.45M | 83.50M | 73.94M | 88.19M | |||
| Selling, General, and Administrative Expenses | 34.45M | 26.42M | 24.61M | 22.83M | |||
| Operating Income | -142.90M | 57.59M | -98.55M | -111.03M | |||
| Interest Income/Expense | 11.78M | -4.18M | -1.86M | -1.51M | |||
| Non Recurring Items | N/A | N/A | 0.00 | -2.40M | |||
| Income Before Taxes | -131.12M | 53.40M | -100.42M | -114.94M | |||
| Income Tax | 0.00 | 1.17M | N/A | N/A | |||
| Net Income | -131.12M | 3.40M | -100.42M | -114.94M | |||
| EBITDA | -140.50M | 60.88M | -94.46M | -107.21M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -3.05 | 0.08 | -2.29 | -2.63 | |||
| Non GAAP EPS | -3.23 | N/A | N/A | N/A | |||
| Statistics | |||||||
| Profit Margin | N/A | 2.03% | N/A | N/A | |||
| Operating Profit Margin | N/A | 34.38% | N/A | N/A | |||
All data in USD